Trxade (MEDS) had the highest return in 2014 by a US stock in the Nasdaq Composite (IXIC), returning 1,122,845.5%.
ASSET | YEAR | % RETURN |
---|---|---|
Trxade (MEDS) | 2014 | 1,122,845.45% |
Ainos (AIMD) | 2014 | 2,057.89% |
Interlink Electronics (LINK) | 2014 | 676.42% |
GT Biopharma (GTBP) | 2014 | 626.22% |
Cyclo Therapeutics (CYTH) | 2014 | 611.9% |
Nocera (NCRA) | 2014 | 600% |
Ammo (POWW) | 2014 | 465.22% |
RadNet (RDNT) | 2014 | 408.33% |
Tempest Therapeutics (TPST) | 2014 | 384.34% |
INVO Bioscience (INVO) | 2014 | 381.48% |
Agios Pharm (AGIO) | 2014 | 371.15% |
Bluebird bio (BLUE) | 2014 | 337.6% |
Applied Blockchain (APLD) | 2014 | 304% |
TG Therapeutics (TGTX) | 2014 | 300% |
OneSpan (OSPN) | 2014 | 265.41% |
Natural Health Trend (NHTC) | 2014 | 254.51% |
Amicus Therapeutics (FOLD) | 2014 | 254.04% |
Immunoprecise Antibodies (IPA) | 2014 | 250% |
Covenant Logistics (CVLG) | 2014 | 230.61% |
Qorvo (QRVO) | 2014 | 223.39% |
Optex Systems Holdings Inc Common Stock (OPXS) | 2014 | 215.79% |
Eastside Distilling (EAST) | 2014 | 215.38% |
Cytosorbents Crp (CTSO) | 2014 | 210.94% |
PTC Therapeutics (PTCT) | 2014 | 209.44% |
Socket Mobile (SCKT) | 2014 | 203.85% |